Poniard Pharmaceuticals Inc Not Moving
{ Posted on Nov 18 2009 by Macroaxis }
| PARD 2.48 | 0.00 0.00%Low: N/A High: N/A Last: 2.48 Volume: 2.48 |
Poniard Pharmaceuticals, Inc. Announces Updated Positive Clinical Data From Phase 2 Trial Of Picoplatin In Colorectal Cancer And New Phase 1 Cardiac Safety Trial Results
Reuters Key Development - 18 hours ago
Reuters Key Development - 18 hours ago
Poniard Pharmaceuticals, Inc. Endures Analyst Downgrade; PARD, ILMN, GENZ
Learning Markets - 22 hours ago
Learning Markets - 22 hours ago
Rodman & Renshaw gave the Biotechnology industry some bad news as it announced a downgrade on one of its stocks. Poniard Pharmaceuticals, Inc. (PARD) [Chart - News - Analysis] was downgraded from ...
Midday Unusual Options Activity Update - HRB, GENZ, SHPGY, TGT, PARD, LOW, PALM, BMY, HD, DELL, MDT, HBC
The Options Insider - Nov 16, 2009
The Options Insider - Nov 16, 2009
H&R Block (HRB) implied volatility is up to 36.7 percent, from about 23 percent two weeks ago, amid active call buying. Shares have been grinding higher and today broke out to their best levels ...
0.00%
Unique in the industry, Macroaxis financial engineering platform delivers measurable value in the form of improved return on your investment portfolios | 

